Relation between regional and global systolic function in patients with ischemic cardiomyopathy after -Blocker therapy or revascularization

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Kaandorp, T A M ^a   Bax, J J ^a   Bleeker, S E ^b   Doornbos, J ^a   Viergever, E P ^a   Poldermans, D ^c   Van Der Wall, E E ^a   De Roos, A ^a   Lamb, H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Laboratory of Public Health Haarlem   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; NITRIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; CHRONIC DISEASE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLE; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHIES; CHRONIC DISEASE; CORONARY ARTERY BYPASS; DOBUTAMINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STROKE VOLUME; SYSTOLE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77952485895     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-7     Document Type: Article

References (33)

1. Heart Disease and Stroke Statistics, 2005 Update. American Heart Association, American Heart Association 2005
2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999 353 2001 2007 10.1016/S0140-6736(99)04440-2 10376614
3. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 353 9 13 10.1016/S0140-6736(98)11181-9 10023943
4. Effect of carvedilol on survival in severe chronic heart failure. M Packer AJ Coats MB Fowler HA Katus H Krum P Mohacsi JL Rouleau M Tendera A Castaigne EB Roecker MK Schultz DL DeMets Carvedilol Prospective Randomized Cumulative Survival Study Group, N Engl J Med 2001 344 1651 1658 10.1056/NEJM200105313442201 11386263
5. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure. JH O'Keefe Jr A Magalski TL Stevens DR Bresnahan Jr K Alaswad SK Krueger TM Bateman, J Nucl Cardiol 2000 7 3 7 10.1067/mnc.2000.102678 10698228
6. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. D Bello DJ Shah GM Farah S Di Luzio M Parker MR Johnson WG Cotts FJ Klocke RO Bonow RM Judd M Gheorghiade RJ Kim, Circulation 2003 108 1945 1953 10.1161/01.CIR.0000095029.57483.60 14557364
7. Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST). EJ Eichhorn PA Grayburn SA Mayer SM St John C Appleton J Plehn J Oh B Greenberg A DeMaria R Frantz H Krause-Steinrauf, Circulation 2003 108 2336 2341 10.1161/01.CIR. 0000097111.00170.7B 14597587
8. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. FF Seghatol DJ Shah S Diluzio D Bello MR Johnson WG Cotts JA O'Donohue RO Bonow M Gheorghiade VH Rigolin, Am J Cardiol 2004 93 854 859 10.1016/j.amjcard.2003.12.023 15050488
9. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. JJ Bax D Poldermans A Elhendy JH Cornel E Boersma R Rambaldi JR Roelandt PM Fioretti, J Am Coll Cardiol 1999 34 163 169 10.1016/S0735-1097(99)00157-6 10400006
10. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. SF Nagueh P Vaduganathan N Ali A Blaustein MS Verani WL Winters Jr WA Zoghbi, J Am Coll Cardiol 1997 29 985 993 10.1016/S0735-1097(97)00001-6 9120185
11. From coronary artery disease to heart failure: role of the hibernating myocardium. SH Rahimtoola, Am J Cardiol 1995 75 16E 22E 10.1016/S0002-9149(99) 80443-3 7726119
12. Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. R Senior A Lahiri S Kaul, Am J Cardiol 2001 88 624 629 10.1016/S0002-9149(01) 01803-3 11564384
13. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. E Nagel HB Lehmkuhl W Bocksch C Klein U Vogel E Frantz A Ellmer S Dreysse E Fleck, Circulation 1999 99 763 770 9989961
14. Left ventricular quantification with breath-hold MR imaging: comparison with echocardiography. JG Bogaert HT Bosmans FE Rademakers EP Bellon MC Herregods JA Verschakelen F Van de Werf GJ Marchal, MAGMA 1995 3 5 12 10.1007/BF02426395 7600177
15. Estimation of human myocardial mass with MR imaging. J Katz MC Milliken J Stray-Gundersen LM Buja RW Parkey JH Mitchell RM Peshock, Radiology 1988 169 495 498 2971985
16. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. PM Pattynama HJ Lamb EA van der Velde EE Van Der Wall A de Roos, Radiology 1993 187 261 268 8451425
17. New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. PC Yang AB Kerr AC Liu DH Liang C Hardy CH Meyer A Macovski JM Pauly BS Hu, J Am Coll Cardiol 1998 32 2049 2056 10.1016/S0735-1097(98)00462-8 9857892
18. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. E Wellnhofer A Olariu C Klein M Grafe A Wahl E Fleck E Nagel, Circulation 2004 109 2172 2174 10.1161/01.CIR.0000128862.34201.74 15117834
19. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. PA Poole-Wilson K Swedberg JG Cleland A Di Lenarda P Hanrath M Komajda J Lubsen B Lutiger M Metra WJ Remme C Torp-Pedersen A Scherhag A Skene Carvedilol Or Metoprolol European Trial Investigators, Lancet 2003 362 7 13 10.1016/S0140-6736(03)13800-7 12853193
20. Echo planar MRI of the heart on a standard system: validation of measurements of left ventricular function and mass. HJ Lamb J Doornbos EA van der Velde MC Kruit JH Reiber A de Roos, J Comput Assist Tomogr 1996 20 942 949 10.1097/00004728-199611000-00014 8933796
21. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. E Wu RM Judd JD Vargas FJ Klocke RO Bonow RJ Kim, Lancet 2001 357 21 28 10.1016/S0140-6736(00)03567-4 11197356
22. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. MD Cerqueira NJ Weissman V Dilsizian AK Jacobs S Kaul WK Laskey DJ Pennell JA Rumberger T Ryan MS Verani American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441
23. Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. ER Holman VG Buller A de Roos RJ van der Geest LH Baur LA van der AV Bruschke JH Reiber EE van der Wall, Circulation 1997 95 924 931 9054752
24. Quantitative prediction of improvement in cardiac function after revascularization with MR imaging and modeling: initial results. JN Oshinski HC Han DN Ku RI Pettigrew, Radiology 2001 221 515 522 10.1148/radiol.2212010124 11687698
25. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. FM Baer P Theissen CA Schneider E Voth U Sechtem H Schicha E Erdmann, J Am Coll Cardiol 1998 31 1040 1048 10.1016/S0735-1097(98)00032-1 9562005
26. beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. S Reiken M Gaburjakova J Gaburjakova KL Kl He A Prieto E Becker GH Gh Yi J Wang D Burkhoff AR Marks, Circulation 2001 104 2843 2848 10.1161/hc4701.099578 11733405
27. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. S Reiken XH Wehrens JA Vest A Barbone S Klotz D Mancini D Burkhoff AR Marks, Circulation 2003 107 2459 2466 10.1161/01.CIR.0000068316.53218.49 12743001
28. Physiologic or pathologic hypertrophy. HP Krayenbuehl OM Hess J Schneider M Turina, Eur Heart J 1983 4 Suppl A 29 34 6220898
29. Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance. TA Kaandorp HJ Lamb JJ Bax E Boersma EP Viergever EE Van Der Wall A de Roos, Heart 2005 91 1471 1472 10.1136/hrt.2004.051425 16230448
30. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. FM Baer E Voth CA Schneider P Theissen H Schicha U Sechtem, Circulation 1995 91 1006 1015 7850935
31. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. JJ Bax JH Cornel FC Visser PM Fioretti A van Lingen JM Huitink O Kamp F Nijland JR Roelandt CA Visser, J Am Coll Cardiol 1997 30 377 383 10.1016/S0735-1097(97)00174-5 9247508
32. The hibernating myocardium. SH Rahimtoola, Am Heart J 1989 117 211 221 10.1016/0002-8703(89)90685-6 2783527
33. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. MG Gunning C Anagnostopoulos CJ Knight J Pepper ED Burman G Davies KM Fox DJ Pennell PJ Ell SR Underwood, Circulation 1998 98 1869 1874 9799206